Loading organizations...
SAIL Venture Partners operates as a venture capital firm, primarily focused on investments within the clean energy and technology sectors. The firm specializes in identifying and funding companies that develop solutions for environmental sustainability, including advancements in battery and energy storage systems, and other emerging cleantech innovations. Its investment strategy targets enterprises poised to make significant impacts in the sustainable technology landscape.
The firm was founded in 2002 by Walter L. Schindler, who initiated SAIL Capital Partners LLC and served as its Managing Partner. Schindler’s foundational insight centered on the critical need for dedicated capital to nurture and scale nascent technologies addressing global environmental challenges, recognizing the long-term potential within the clean technology market. This vision informed the firm’s early establishment and subsequent investment mandates.
SAIL Venture Partners collaborates with entrepreneurs and growing companies dedicated to environmental innovation. The firm's long-term vision is to support the development and widespread adoption of sustainable technologies, thereby contributing to a more energy-efficient and environmentally responsible future. It continues to seek out and empower businesses that align with its core mission of fostering ecological advancement through strategic investment.
SAIL Venture Partners has 3 tracked investments across 2 companies. The latest tracked deal is $50.0M Series C in Hua Medicine in April 2016.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2016 | Hua Medicine | $50.0M Series C | Harvest Investments | ARCH Venture Partners, Flagship Ventures, F Prime Capital, Meritech Capital Partners, Venrock, Ally Bridge Group, Fidelity Management & Research Company, Frontline BioVentures Arch, TF Capital, WuXi Healthcare Ventures |
| Jan 1, 2015 | Hua Medicine | $25.0M Series B | Ally Bridge Group | ARCH Venture Partners, Flagship Ventures, F Prime Capital, Meritech Capital Partners, Venrock, Fidelity Management & Research Company, Frontline BioVentures, TF Capital, WuXi Healthcare Ventures |
| Jul 11, 2011 | Xtreme Power Conversion | $16.4M Other Equity | — | Bessemer Venture Partners, Skylake Equity Partners, Spring Ventures, The DOW Chemical Company |